Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows (unaudited)

v3.25.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Cash flows from operating activities:    
Net income $ 18.6 $ 22.7
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 31.9 31.7
Loss on disposal of assets 0.1 0.0
Stock-based compensation expense 2.9 6.7
Amortization of debt issuance costs 0.4 0.7
Benefit for deferred income taxes (1.4) (1.3)
Other, net 0.5 0.8
(Increase) decrease in:    
Accounts receivable (23.4) (19.5)
Inventories (1.7) 6.3
Income taxes receivable 6.5 1.2
Other current assets 2.1 (6.0)
Other assets (1.3) 3.9
Increase (decrease) in:    
Accounts payable 21.4 (1.9)
Accrued expenses and other liabilities 4.2 5.2
Income taxes payable (2.8) 4.0
Other noncurrent liabilities (2.0) (2.9)
Net cash provided by operating activities 56.0 51.6
Cash flows from investing activities:    
Capital expenditures (11.5) (13.6)
Proceeds from dispositions of property, plant and equipment 0.2 0.0
Software development costs (1.9) (1.8)
Net cash used in investing activities (13.2) (15.4)
Cash flows from financing activities:    
Borrowings on revolving credit facilities 20.6 37.1
Repayment of borrowings on revolving credit facilities (38.4) (43.6)
Borrowings on long-term non-revolving debt 0.0 126.8
Repayment of borrowings on long-term non-revolving debt (7.8) (138.5)
Proceeds from stock issued 0.9 1.0
Purchase of treasury stock (6.5) 0.0
Dividends to shareholders (6.0) (6.0)
Payment of employee tax withholding on equity award vestings (0.5) (2.4)
Proceeds received upon termination of Cash Flow hedge instruments 0.0 7.1
Other financing activities (0.8) (4.1)
Net cash used in financing activities (38.5) (22.6)
Effect of exchange rate changes on cash and cash equivalents 4.6 (1.0)
Net increase in cash and cash equivalents 8.9 12.6
Cash and cash equivalents, beginning of period 44.1 32.4
Cash and cash equivalents, end of period $ 53.0 $ 45.0